Hypotensive therapу of secondary glaucoma in patients with endocrine ophthalmopathy
https://doi.org/10.51523/2708-6011.2021-18-2-7
Abstract
Objective: to evaluate the efficiency of monotherapy and fixed combination therapy of secondary glaucoma (SG) in patients with endocrine ophthalmopathy (EOP).
Materials and methods. We examined 145 patients (290 eyes and orbits) with different forms and activity of EOP. Among them, 30 patients (58 eyes and orbits) were diagnosed with ″SG detected for the first time and associated with EOP″ (20 % of the cases).
The patients with SG received beta-adrenoblockers (BA) or prostaglandin analogues (PGA) as initial monotherapy. Two weeks later, in the absence of intraocular pressure (IOP) compensation, fixed combinations of beta-blocker/carbonic or anhydrase inhibitor (BB/CAI) or beta-blocker/prostaglandin analogue (BB/ PGA) were prescribed.
Results. The PGA monotherapy reduced the IOP level by 29 % compared to the baseline level in 33 % of the cases in increased ophthalmic tonus within Me 27 [26;28] mm Hg. (Wilcoxon test, p = 0.005). In IOP levels over 29 [28;31] mmHg, BB/PGA fixed combination therapy reduced IOP by 33 % from the baseline level.
Conclusion. SG monotherapy in patients with EOP is effective in increased IOP within Me 27 [26;28] mmHg. In initial IOP levels higher than 29 [28;31] mmHg, it is expedient to prescribe BB/PGA fixed combination therapy as initial therapy.
About the Author
O. P. Sadovskaya
Gomel State Medical University
Belarus
Belarus
Olga P. Sadovskaya, Assistant Lecturer at the Course of Ophthalmology
Gomel
References
1. Aleshaev MI. Faktory riska razvitiya pervichnoy otkrytougol’noy glaukomy. Penza, RF: GOU DPO PIU; 2009. 14 p. (in Russ.)
2. Erichev VP, Onishchenko AL, Kuroedov AV, Petrov SYu, Brezhnev AYu, Antonov AA i dr. Oftal’mologicheskie faktory riska razvitiya pervichnoy otkrytougol’noy glaukomy. Klinicheskaya Oftal’mologiya. 2019;19(2):81–86. https://doi.org/10.32364/2311-7729-2019-19-2-81-86 (in Russ.)
3. Song R, Wang B, Yao Q, Li Q, Jia X and Zhang J. The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis. Front. Immunol. 2019 Oct 1;10:2349. https://doi.org/10.3389/fimmu.2019.02349
4. Dedov II, Troshina EA, Antonova SS. Autoimmunnye zabolevaniya shchitovidnoy zhelezy: sostoyanie problemy. Problemy Endokrinologii. 2002;48(2):6–13. https://doi.org/10.14341/probl11500
5. Brovkina AF. Endocrine ophatholmopathy. Moscow, RF: Geotar Media; 2008. 176 p. (in Russ.)
6. Carballo M, De Sá B, Rocha D, Arbex A. Pathophysiology of Graves’ Ophthalmopathy: A Literature Review. Open Journal of Endocrine and Metabolic Diseases. 2017;7(1):77–87. https://doi.org/10.4236/ojemd.2017.71008
7. Gontarz-Nowak K, Szychlińska M, Matuszewski W, Stefanowicz-Rutkowska M, Bandurska-Stankiewicz E. Current Knowledge on Graves’ Orbitopathy. J Clin Med. 2021 Dec 23;10(1):16. https://doi.org/10.3390/jcm10010016
8. Brovkina A.F. Optic neuropathy and exophthalmos edematous: symptom or complication? Ophthalmology Journal. 2020;13(1):71–76. (in Russ.). https://doi.org/10.17816/OV25334
9. Yatsenko OYu, Tyurin IE. X-ray semiotics of endocrine ophthalmopathy. Part 1. Extraocular muscles and orbital cellular tissue. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2016;97(3):133–142. (in Russ.). https://doi.org/10.20862/0042-4676-2016-97-3-133-142
10. Potemkin VV, Goltsman EV, Kovaleva M. Episcleral venous pressure level in patients with thyroid associated orbitopathy. Ophthalmology Journal. 2018;11(3):2–25. (in Russ.) https://doi.org/10.17816/OV11321-25
11. Likhvantseva VG, Korosteleva EV, Kovelenova IV, Budanov SV, Ben Rezh A. Deficiency of eye blood flow as a key factor determining the form of secondary glaucoma in endocrine ophthalmopathy. Russian Ophthalmological Journal 2016;9(3):43–49. (in Russ.). https://doi.org/10.1016/0014-4835(92)90793-r
12. Dravitsa LV, Sadovskaya OP, Shestakova NA. Eye hydrodynamics in patients with different forms of endocrine. Ophthalmology. Eastern Europe. 2018;8(2):98–205. (in Russ.). http://elib.gsmu.by/handle/GomSMU/3908
13. Cross JM, Girkin CA, Owsley C, McGwin G Jr. The association between thyroid problems and glaucoma. Br J Ophthalmol. 2008;92(11):1503–1505. https://doi.org/10.1136/bjo.2008.147165
Review
For citations:
Sadovskaya O.P. Hypotensive therapу of secondary glaucoma in patients with endocrine ophthalmopathy. Health and Ecology Issues. 2021;18(2):48-54. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-2-7
Views: 340
Email this article 